Amneal Corp (AMRX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Amneal Pharmaceuticals (AMRX) murakkab inyeksiyalar va biosimilarlarining keng portfeli hisobiga barqaror iqtisodiy ustunlikka tayanadi. Uzoq muddatli qarzlarning bozor tendentsiyasi, monetar ifodada 79.92 ko'rinishida namoyon bo'lmoqda. Asoschi jamoa xarajatlarni optimallashtirgan holda mahsulotlar liniyasini mahorat bilan kengaytirmoqda. Biznes bozor sikllariga nisbatan past sezuvchanlikni namoyish etmoqda, chunki iqtisodiy pasayish davrida hamyonbop terapiyaga bo'lgan talab ortadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_AMRX_-_Amneal-Pharmaceuticals_-_Long-Term-Debt-to-Capital "AMRX: Amneal Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 01.11.2026 | 👁️GURU.Markets👁️")
Amneal Pharmaceuticals (AMRX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Amneal Pharmaceuticals|AMRX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati amneal.com|AMRX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Amneal|AMRX - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Amneal Pharmaceuticals|Oraliq likvidlik koeffitsiyenti amneal.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Amneal Pharmaceuticals, Inc. - AMRX
Amneal Pharmaceuticals (AMRX) kompaniyasining generiklar segmentidagi raqobatlashish qobiliyati birlik xarajatlarini kamaytirish uchun ishlab chiqarish quvvatlariga kiritiladigan keng ko'lamli investitsiyalarga bog'liq. GURU.Markets grafigida ko'rsatilgan 79.92 miqdoridagi uzoq muddatli qarzlarning o'z kapitaliga nisbati uzoq muddatli kreditlar va kapital o'rtasidagi muvozanatni miqdoriy baholaydi, bu esa investorlarga kapital talab qiladigan kengayish strategiyalarini amalga oshirishda moliyaviy barqarorlik va defolt xavfini baholash imkonini beradi.
Raqobatdosh kompaniyalar tahlili
Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|PRGO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti ALVO (Alvotech S.A.)|Liquidia Technologies (LQDA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Galapagos Corp|ANIP (ANI Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati mannkindcorp.com|Uzoq muddatli qarzning o'z kapitaliga nisbati AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Pharmaceuticals) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati ARS Pharma SPRY|Theravance Corp (TBPH) - Uzoq muddatli majburiyatlarning kapitalga nisbati|AQST: Uzoq muddatli qarzning o'z kapitaliga nisbati|scPharmaceuticals Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ORMP (Oramed Pharmaceuticals Inc.)|Uzoq muddatli qarzning kapitalga nisbati Entera Bio Ltd ENTX|HYFT - Uzoq muddatli qarzning o'z kapitaliga nisbati|ABVC BioPharma, Inc (ABVC) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cumberland Pharmaceuticals (CPIX) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi QNTM|FGEN (FibroGen) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Telomir Pharmaceuticals Inc TELO|Uzoq muddatli qarzning kapitalga nisbati RANI|Uzoq muddatli qarzning kapitalga nisbati synergychc.com (SNYR)|Uzoq muddatli qarzning o'z kapitaliga nisbati Rallybio RLYB|Lexaria Bioscience Corp - Uzoq muddatli qarzning o'z kapitaliga nisbati|PULM: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PTHL (Pheton Holdings Ltd)|aptorumgroup.com (APM) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati LYRA (Lyra Therapeutics Inc)|IBO (Impact BioMedical Inc) - Uzoq muddatli qarzning kapitalga nisbati|TNFA: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati YCBD|Uzoq muddatli qarzning kapitalga nisbati PainReform Ltd (PRFX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Altamira Therapeutics Ltd. CYTO|Uzoq muddatli qarzning kapitalga koeffitsiyenti LIPO|OPTN - Uzoq muddatli qarzning o'z kapitaliga nisbati|pieris.com (PIRS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|PROC: Uzoq muddatli qarzning kapitalga nisbati|Petros Pharmaceuticals Inc (PTPI) - Uzoq muddatli qarzning kapitalga nisbati|QLI (Qilian International Holding Group Limited) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati ACELYRIN Inc. (SLRN)|Uzoq muddatli qarzning kapitalga nisbati TFFP